1. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49(RR-10):1–125, CE121–7.
2. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008–09 influenza season. CDC Health Advisory, distributed via Health Alert Network. 12/19/08; http://www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV.asp?AlertNum=00279 (2009). Accessed 22 Jan 2009.
3. Schnipper LE, Crumpacker CS, Marlowe SI, Kowalsky P, Hershey BJ, Levin MJ. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient. Am J Med. 1982;73(1A):387–92.
4. Field HJ, Larder BA, Darby G. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus. Am J Med. 1982;73(1A):369–71.
5. Burns WH, Saral R, Santos GW. Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet. 1982;1(8269):421–3.